Vor Biopharma Inc. VOR
- telitacicept — Generalized Myasthenia Gravis Phase 3
- telitacicept — Sjögren's Disease Phase 3
BLyS (1 companies · 2 programs)
Companies with an active program directed at BLyS.
Companies with an active program directed at BLyS.